Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy

Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint inflammation, progressive tissue damage and significant disability, severely impacting patients’ quality of life. While the exact mechanisms underlying RA remain elusive, growing evidence suggests a strong link between int...

Full description

Saved in:
Bibliographic Details
Main Authors: Vitaly Chasov, Elvina Gilyazova, Irina Ganeeva, Ekaterina Zmievskaya, Damir Davletshin, Aygul Valiullina, Emil Bulatov
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/12/1653
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846105561481871360
author Vitaly Chasov
Elvina Gilyazova
Irina Ganeeva
Ekaterina Zmievskaya
Damir Davletshin
Aygul Valiullina
Emil Bulatov
author_facet Vitaly Chasov
Elvina Gilyazova
Irina Ganeeva
Ekaterina Zmievskaya
Damir Davletshin
Aygul Valiullina
Emil Bulatov
author_sort Vitaly Chasov
collection DOAJ
description Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint inflammation, progressive tissue damage and significant disability, severely impacting patients’ quality of life. While the exact mechanisms underlying RA remain elusive, growing evidence suggests a strong link between intestinal microbiota dysbiosis and the disease’s development and progression. Differences in microbial composition between healthy individuals and RA patients point to the role of gut microbiota in modulating immune responses and promoting inflammation. Therapies targeting microbiota restoration have demonstrated promise in improving treatment efficacy, enhancing patient outcomes and slowing disease progression. However, the complex interplay between gut microbiota and autoimmune pathways in RA requires further investigation to establish causative relationships and mechanisms. Here, we review the current understanding of the gut microbiota’s role in RA pathogenesis and its potential as a therapeutic target.
format Article
id doaj-art-51b0b27023bd4744b2aabf75b5a614e4
institution Kabale University
issn 2218-273X
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj-art-51b0b27023bd4744b2aabf75b5a614e42024-12-27T14:14:04ZengMDPI AGBiomolecules2218-273X2024-12-011412165310.3390/biom14121653Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis TherapyVitaly Chasov0Elvina Gilyazova1Irina Ganeeva2Ekaterina Zmievskaya3Damir Davletshin4Aygul Valiullina5Emil Bulatov6Laboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaLaboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaLaboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaLaboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaLaboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaLaboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaLaboratory of Biomedical Technologies, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya Street, Kazan 420008, RussiaRheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint inflammation, progressive tissue damage and significant disability, severely impacting patients’ quality of life. While the exact mechanisms underlying RA remain elusive, growing evidence suggests a strong link between intestinal microbiota dysbiosis and the disease’s development and progression. Differences in microbial composition between healthy individuals and RA patients point to the role of gut microbiota in modulating immune responses and promoting inflammation. Therapies targeting microbiota restoration have demonstrated promise in improving treatment efficacy, enhancing patient outcomes and slowing disease progression. However, the complex interplay between gut microbiota and autoimmune pathways in RA requires further investigation to establish causative relationships and mechanisms. Here, we review the current understanding of the gut microbiota’s role in RA pathogenesis and its potential as a therapeutic target.https://www.mdpi.com/2218-273X/14/12/1653rheumatoid arthritisgut microbiotadysbiosisbacterial translocationmolecular mimicrybacterial metabolites
spellingShingle Vitaly Chasov
Elvina Gilyazova
Irina Ganeeva
Ekaterina Zmievskaya
Damir Davletshin
Aygul Valiullina
Emil Bulatov
Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
Biomolecules
rheumatoid arthritis
gut microbiota
dysbiosis
bacterial translocation
molecular mimicry
bacterial metabolites
title Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
title_full Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
title_fullStr Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
title_full_unstemmed Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
title_short Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy
title_sort gut microbiota modulation a novel strategy for rheumatoid arthritis therapy
topic rheumatoid arthritis
gut microbiota
dysbiosis
bacterial translocation
molecular mimicry
bacterial metabolites
url https://www.mdpi.com/2218-273X/14/12/1653
work_keys_str_mv AT vitalychasov gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy
AT elvinagilyazova gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy
AT irinaganeeva gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy
AT ekaterinazmievskaya gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy
AT damirdavletshin gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy
AT aygulvaliullina gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy
AT emilbulatov gutmicrobiotamodulationanovelstrategyforrheumatoidarthritistherapy